Beta-blocker atenolol is a well-known anti-hypertensive drug that has tendency to cause changes in the patient's normal lipid profile.Aim: This study aims to prevent this harmful impact of Atenolol utilising Glycine max seeds, a cost-effective, widely accessible nutraceutical that is more physiologically compatible than other choices.
Materials and Method:Wistar rats were given a diet with 8% sodium chloride to induce hypertension and subsequently sacrificed. Glycine max powder was used to reduce atenolol's side effects during the trial. Thirty rats were divided into five groups and tested over eight weeks. Rats' blood pressure (BP) was measured with a tail-cuff NIBP monitor. Biochemical markers like TG, TC, HDL, LDL, VLDL, alanine transferase, aspartate transferase, lipid peroxide (LPO), catalase, and super oxide dismutase (SOD) were evaluated.Results: Glycine max seeds may minimize the effects of Atenolol on the lipid profile by reducing blood cholesterol, increasing antioxidant levels, and maintaining liver function. When glycine max and Atenolol were administered together, there was a substantial decrease in TC, TG, LDL, VLDL, and HDL levels, SOD, catalase and increase in MDA, AST and ALT as compared to the normal control group (p≤0.05).Conclusion: SBP (systolic blood pressure) and DBP (diastolic blood pressure) are lowered considerably compared to a control diet, however the amount depends on pre-treatment BP measurements and baseline comparison diet. Combining Atenolol with glycine max not only improves blood pressure but also modifies lipid profile. In rats with atenolol-induced hyperlipidemia, glycine max reduces oxidative stress and liver damage.